Related Experiment Video
Updated: Jun 10, 2025

Vinyl Chloride and High-Fat Diet as a Model of Environment and Obesity Interaction
Published on: January 12, 2020
The interplay of dietary mycotoxins and oncogenic viruses toward human carcinogenesis: a scoping review
Thanos Mouchtaris Michailidis1,2,3, Sarah De Saeger1,2,4, Rita Khoueiry3
1Faculty of Pharmaceutical Sciences, Centre of Excellence in Mycotoxicology and Public Health, Ghent University, Ghent, Belgium.
Background:
Mycotoxins, fungal metabolites prevalent in many foods, are recognized for their role in carcinogenesis, especially when interacting with oncogenic viruses.
Objectives:
This scoping review synthesizes current evidence on the human cancer risk associated with mycotoxin exposure and oncogenic virus infections.
Methods:
Searches were conducted on PubMed, Embase, and Web of Science. Studies were selected based on the PECOS framework. Data extraction involved narrative and qualitative presentation of findings, with meta-analysis where feasible. Risk of bias and outcome quality were assessed using the OHAT tool and GRADE approach.
Results:
From 25 included studies, 18 focused on aflatoxins and hepatitis viruses in hepatocellular carcinoma (HCC). Four studies examined aflatoxin B1 (AFB1) and human papilloma virus (HPV) in cervical cancer, while three investigated AFB1 with Epstein-Barr virus (EBV) in lymphomagenesis. The review highlights a significant synergistic effect between AFB1 and hepatitis B and C viruses in HCC development. Significant interactions between AFB1 and HPV, as well as AFB1 and EBV, were observed, but further research is needed.
Conclusions:
The synergistic impact of mycotoxins and oncogenic viruses is a critical public health concern. Future research, especially prospective cohort studies and investigations into molecular mechanisms, is essential to address this complex issue.
Insights
Mycotoxins like aflatoxin B1 (AFB1) significantly increase cancer risk when combined with oncogenic viruses. This synergistic effect is notable for hepatitis viruses in liver cancer and warrants further investigation for HPV and EBV.
Area of Science:
- Toxicology
- Oncology
- Virology
Background:
- Mycotoxins are fungal metabolites found in food with known carcinogenic potential.
- Their interaction with oncogenic viruses amplifies cancer risk.
Purpose of the Study:
- To review and synthesize evidence on human cancer risk from mycotoxin exposure and oncogenic virus infections.
- To identify synergistic effects between mycotoxins and viruses in cancer development.
Main Methods:
- Scoping review of studies from PubMed, Embase, and Web of Science.
- Data extraction using the PECOS framework, with narrative and qualitative synthesis.
- Risk of bias and outcome quality assessed using OHAT and GRADE.
Main Results:
- Aflatoxins (AFB1) and hepatitis viruses show a significant synergistic effect in hepatocellular carcinoma (HCC).
- AFB1 interactions with human papilloma virus (HPV) and Epstein-Barr virus (EBV) were observed but require more research.
- 25 studies were included, with a focus on AFB1 in HCC, cervical cancer, and lymphoma.
Conclusions:
- The combined impact of mycotoxins and oncogenic viruses poses a significant public health risk.
- Further research, including prospective studies and molecular mechanism investigations, is crucial.
More Related Videos
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
Related Concept Videos
Mutagenicity and Carcinogenicity
Mechanisms of Retrovirus-induced Cancers
Induced Pluripotent Stem Cells
Somatic...
Cancer Prevention
Some...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...